Septerna SEPN
NASDAQ SEPN
$39.13 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Septerna (SEPN) Current Deferred Revenue (2025 - 2026)

Updated

Septerna's Current Deferred Revenue came in at $60.35 million for Q2 2026, up 1.0% from the prior quarter.

Analysis

Septerna (SEPN) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Septerna's Current Deferred Revenue was $62.27 million.

  • The five-year range for quarterly Current Deferred Revenue is $59.76 million (Q1 2026) to $62.27 million (Q4 2025).
  • Business Quant data shows SEPN's Current Deferred Revenue at $59.76 million (Q1 2026), $62.27 million (Q4 2025) and $61.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Septerna 1.79 Bn 1.79 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.35 Mn
Mar 31, 2026 59.76 Mn
Dec 31, 2025 62.27 Mn
Sep 30, 2025 61.60 Mn
API Access

Septerna Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SEPN&period=max&api_key=YOUR_API_KEY